Internal Medicine, Nephrology · Hazard, KY
NPI
1265619456
Since 2008
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
200 Medical Center Dr
Hazard, KY, 41701
Phone (606) 487-7991
Groups this clinician bills Medicare through
Medicare paid, 2024
$140K
1,020 services
Medicare patients, 2024
153
Average age 71
Drug cost, 2024
$710K
1,057 prescriptions
Company payments, 2024
$16.51
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Boonsong K Kitiwan was code 99232 (hospital e&m - subsequent), 461 times for 108 patients. In total Boonsong K Kitiwan billed 1,020 services in 12 codes, and Medicare paid $140K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 461 | 108 | $61.10 | $28K |
| 90960 ESRD Related Services (not dialysis) | Office | 221 | 43 | $274.56 | $61K |
| 90961 ESRD Related Services (not dialysis) | Office | 111 | 33 | $228.35 | $25K |
| 99222 Hospital E&M - Initial | Facility | 87 | 74 | $100.93 | $8,781 |
| 99233 Hospital E&M - Subsequent | Facility | 65 | 31 | $91.42 | $5,942 |
| 90962 ESRD Related Services (not dialysis) | Office | 37 | 25 | $156.96 | $5,808 |
| 99223 Hospital E&M - Initial | Facility | 13 | 13 | $135.32 | $1,759 |
By year: 2022 $199K for 1,554 services; 2023 $153K for 1,120 services; 2024 $140K for 1,020 services.
Medicare prescription drug claims, 2024
In 2024, the drug Boonsong K Kitiwan prescribed most often to Medicare patients was Sevelamer Carbonate, with 197 prescriptions and refills. In total Boonsong K Kitiwan wrote 1,057 Medicare prescriptions that cost $710K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sevelamer Carbonate Generic | 197 | 253 | 37 | $21K |
| Velphoro Sucroferric Oxyhydroxide | 170 | 178 | 27 | $553K |
| Lanthanum Carbonate Generic | 78 | 90 | 14 | $71K |
| Calcium Acetate Generic | 70 | 78 | Under 11 | $4,063 |
| Furosemide Generic | 50 | 59 | 15 | $101 |
| Hydralazine Hcl Generic | 44 | 66 | 14 | $276 |
| Potassium Chloride Generic | 41 | 53 | 14 | $571 |
| Nifedipine Er Nifedipine | 39 | 63 | 13 | $786 |
| Renvela Sevelamer Carbonate | 27 | 27 | Under 11 | $32K |
| Lokelma Sodium Zirconium Cyclosilicate | 27 | 27 | Under 11 | $13K |
| Bumetanide Generic | 24 | 39 | Under 11 | $1,046 |
| Losartan Potassium Generic | 23 | 39 | Under 11 | $88.23 |
| Amlodipine Besylate Generic | 23 | 39 | Under 11 | $41.53 |
| Calcitriol Generic | 15 | 25 | Under 11 | $281 |
| Hydrochlorothiazide Generic | 14 | 24 | Under 11 | $67.28 |
Brand drugs: 278 claims; generic drugs: 779 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Boonsong K Kitiwan $16.51 ($16.51 in general payments such as food, travel and fees) from 1 company. The largest payer was Fresenius USA Marketing, Inc. with $16.51.
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 1 | $16.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.